SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹17 Cr | ₹14 Cr | ₹43 Cr | ₹12 Cr | ₹7.04 Cr |
What is the latest Total Current Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹7.04 Cr |
How is Total Current Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 22.12 | |
| Mar2024 | ₹14 Cr | -66.70 | |
| Mar2023 | ₹43 Cr | 243.46 | |
| Mar2022 | ₹12 Cr | 75.92 | |
| Mar2021 | ₹7.04 Cr | - | |
Compare Total Current Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,526.7 Cr | 2.9% | 15.9% | 85.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 2.9% |
15.9% |
85.4% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses